AringerMCostenbaderKDaikhD, et al.2019 European League against rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol2019; 71: 1400–1412.
2.
HolzingerDJornsCStertzS, et al.Induction of MxA gene expression by influenza A virus requires type I or type III interferon signaling. J Virol2007; 81: 7776–7785.
3.
RonniTMelénKMalyginA, et al.Control of IFN-inducible MxA gene expression in human cells. J Immunol1993; 150: 1715–1726.
4.
LodiLMastroliaMVBelloF, et al.Type I interferon–related kidney disorders. Kidney Int2022; 101: 1142–1159.
5.
GaoSvon der MalsburgADickA, et al.Structure of myxovirus resistance protein a reveals intra-and intermolecular domain interactions required for the antiviral function. Immunity2011; 35: 514–525.
6.
CrowMK. Advances in understanding the role of type I interferons in systemic lupus erythematosus. Curr Opin Rheumatol2014; 26: 467–474.
7.
PengLOganesyanVWuH, et al.Molecular basis for antagonistic activity of anifrolumab, an anti-interferon–α receptor 1 antibody. Oxfordshire: Taylor & Francis, 2015, pp. 428–439.
